Skip to main content

Advertisement

SpringerLink
Log in

Hyperlipidemia in Iranian liver transplant recipients: prevalence and risk factors

  • Liver, Pancreas, and Biliary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

Hyperlipidemia is a metabolic complication after liver transplantation (LT). The aim of this study was to investigate the prevalence and risk factors for developing hyperlipidemia in patients who underwent LT in the Shiraz Organ Transplantation Center.

Methods

Our patients were 170 liver recipients who underwent LT from 1994 to 2006 in the Organ Transplantation Center of the Shiraz University of Medical Sciences. To perform this study we administered questionnaires, including information about age, sex, body mass index (BMI), underlying liver disease, graft type, immunosuppressive medications, and serum levels of triglycerides and cholesterol, before and 6 months after LT. Serum triglyceride and cholesterol levels were considered elevated if they were >150 mg/dl and >250 mg/dl, respectively. Data were analyzed with SPSS software.

Results

There were 108 male and 62 female patients, with a mean age of 31.4 ± 13.3 years, and the mean duration of follow-up was 25.9 ± 23.5 months. The average pretransplant serum triglyceride and cholesterol (mean of individual means) levels were 104.6 ± 73.2 and 109.5 ± 51.5 mg/dl, respectively, and the average posttransplant levels were 230.1 ± 131 and 185 ± 77 mg/dl, respectively. Six months after LT, 119 (70%) and 26 (15.3%) patients developed hypertriglyceridemia and hypercholesterolemia, respectively. Age, sex, BMI, and underlying liver disease were not predictors of hypertriglyceridemia or hypercholesterolemia (P > 0.05). Posttransplant hypertriglyceridemia was significantly more common in patients receiving tacrolimus than in those receiving cyclosporine (P = 0.040), but posttransplant hypercholesterolemia had no significant correlation with type of immune suppression (P > 0.05).

Conclusions

Hyperlipidemia was common after LT, and hypertriglyceridemia was more common than hypercholesterolemia. Among all risk factors, tacrolimus therapy was correlated with development of hypertriglyceridemia after LT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. SJ Munoz RO Deems MJ Moritz P Martin BE Jarrell WC Maddrey (1991) ArticleTitleHyperlipidemia and obesity after orthotopic liver transplantation Transplant Proc 23 IssueID1 Pt 2 1480–3 Occurrence Handle1989271 Occurrence Handle1:STN:280:DyaK3M7htFKntw%3D%3D

    PubMed  CAS  Google Scholar 

  2. RM Jindal I Popescu S Emre ME Schwartz P Boccagni P Meneses et al. (1994) ArticleTitleSerum lipid changes in liver transplant recipients in a prospective trial of cyclosporine versus FK506 Transplantation 57 1395–8 Occurrence Handle7514317 Occurrence Handle10.1097/00007890-199402000-00001 Occurrence Handle1:STN:280:DyaK2c3ktVOmsg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  3. DK Imagawa S Dawson CD Holt PS Kirk FM Kaldas CR Shackleton et al. (1996) ArticleTitleHyperlipidemia after liver transplantation: natural history and treatment with the hydroxy-methylglutaryl-coenzyme A reductase inhibitor pravastatin Transplantation 62 934–42 Occurrence Handle8878387 Occurrence Handle10.1097/00007890-199610150-00011 Occurrence Handle1:CAS:528:DyaK28XmvFKrsLk%3D

    Article  PubMed  CAS  Google Scholar 

  4. JA Kobashigawa BL Kasiske (1997) ArticleTitleHyperlipidemia in solid organ transplantation Transplantation 63 331–8 Occurrence Handle9039919 Occurrence Handle10.1097/00007890-199702150-00001 Occurrence Handle1:STN:280:DyaK2s7pt1Wjsg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  5. SD Johnston JK Morris R Cramb BK Gunson J Neuberger (2002) ArticleTitleCardiovascular morbidity and mortality after orthotopic liver transplantation Transplantation 73 901–6 Occurrence Handle11923689 Occurrence Handle10.1097/00007890-200203270-00012

    Article  PubMed  Google Scholar 

  6. O Guckelberger WO Bechstein R Neuhaus R Luesebrink HP Lemmens B Kratschmer et al. (1997) ArticleTitleCardiovascular risk factors in long-term follow-up after orthotopic liver transplantation Clin Transpl 11 60–5 Occurrence Handle1:STN:280:DyaK2s3itVGgtw%3D%3D

    CAS  Google Scholar 

  7. J Pratschke R Neuhaus SG Tullius GW Haller S Jonas T Steinmueller et al. (1997) ArticleTitleTreatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation Transplantation 64 938–40 Occurrence Handle9326428 Occurrence Handle10.1097/00007890-199709270-00029 Occurrence Handle1:CAS:528:DyaK2sXmslCntro%3D

    Article  PubMed  CAS  Google Scholar 

  8. DA Neal AE Gimson P Gibbs GJ Alexander (2001) ArticleTitleBeneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight Liver Transpl 7 533–9 Occurrence Handle11443583 Occurrence Handle10.1053/jlts.2001.24637 Occurrence Handle1:STN:280:DC%2BD3MzoslGjtQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  9. C Manzarbeitia DJ Reich KD Rothstein LE Braitman S Levin SJ Munoz (2001) ArticleTitleTacrolimus conversion improves hyperlipidemic states in stable liver transplant recipients Liver Transpl 7 93–9 Occurrence Handle11172391 Occurrence Handle10.1053/jlts.2001.21289 Occurrence Handle1:STN:280:DC%2BD3M3ksVCrsg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  10. A Siirtola M Antikainen M Ala-Houhala AM Koivisto T Solakivi SM Virtanen et al. (2005) ArticleTitleInsulin resistance, LDL particle size, and LDL susceptibility to oxidation in pediatric kidney and liver recipients Kidney Int 67 2046–55 Occurrence Handle15840056 Occurrence Handle10.1111/j.1523-1755.2005.00307.x Occurrence Handle1:CAS:528:DC%2BD2MXktlyjsrk%3D

    Article  PubMed  CAS  Google Scholar 

  11. JS Hyams WR Treem WS Andrews PN Herbert (1989) ArticleTitleLipid abnormalities in pediatric hepatic allograft recipients J Pediatr Gastroenterol Nutr 9 441–4 Occurrence Handle2621521 Occurrence Handle1:STN:280:DyaK3c7lsFOisQ%3D%3D Occurrence Handle10.1097/00005176-198911000-00008

    Article  PubMed  CAS  Google Scholar 

  12. M Kanbay A Yildirir A Akcay T Colak FN Ozdemir H Muderrisoglu et al. (2006) ArticleTitleEffects of immunosuppressive drugs on serum lipid levels in renal transplant recipients Transplant Proc 38 502–5 Occurrence Handle16549160 Occurrence Handle10.1016/j.transproceed.2005.12.052 Occurrence Handle1:CAS:528:DC%2BD28Xis1aqsLo%3D

    Article  PubMed  CAS  Google Scholar 

  13. E Granot (1998) ArticleTitleLipoprotein changes in children after liver transplantation: mild hypertriglyceridemia and a decrease in HDL3/HDL2 ratio Hepatology 27 175–80 Occurrence Handle9425934 Occurrence Handle10.1002/hep.510270127 Occurrence Handle1:CAS:528:DyaK1cXlvVCjsw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  14. A Siirtola A Ketomaki TA Miettinen H Gylling T Lehtimaki C Holmberg et al. (2006) ArticleTitleCholesterol absorption and synthesis in pediatric kidney, liver, and heart transplant recipients Transplantation 81 327–34 Occurrence Handle16477216 Occurrence Handle10.1097/01.tp.0000189173.46727.18 Occurrence Handle1:CAS:528:DC%2BD28XhtlGktb0%3D

    Article  PubMed  CAS  Google Scholar 

  15. T Quaschning T Mainka M Nauck LC Rump C Wanner A Kramer-Guth (1999) ArticleTitleImmunosuppression enhances atherogenicity of lipid profile after transplantation Kidney Int 71 IssueIDSupp1 S235–7 Occurrence Handle10.1046/j.1523-1755.1999.07162.x Occurrence Handle1:CAS:528:DyaK1MXksVaitb4%3D

    Article  CAS  Google Scholar 

  16. F Cofan M Cofan B Campos R Guerra JM Campistol F Oppenheimer (2005) ArticleTitleEffect of calcineurin inhibitors on low-density lipoprotein oxidation Transplant Proc 37 3791–3 Occurrence Handle16386540 Occurrence Handle10.1016/j.transproceed.2005.10.068 Occurrence Handle1:CAS:528:DC%2BD28XksVWm

    Article  PubMed  CAS  Google Scholar 

  17. S Devaraj DJ Li M Vazquez I Jialal (1999) ArticleTitleCyclosporine A does not increase the oxidative susceptibility of low density lipoprotein in vitro Free Radic Biol Med 26 1064–8 Occurrence Handle10232852 Occurrence Handle10.1016/S0891-5849(98)00320-7 Occurrence Handle1:CAS:528:DyaK1MXislGktrg%3D

    Article  PubMed  CAS  Google Scholar 

  18. H Hohage U Welling M Heck M Zeh U Gerhardt BM Suwelack (2005) ArticleTitleConversion from cyclosporine to tacrolimus after renal transplantation improves cardiovascular risk factors Int Immunopharmacol 5 117–23 Occurrence Handle15589469 Occurrence Handle10.1016/j.intimp.2004.09.012 Occurrence Handle1:CAS:528:DC%2BD2cXhtVKls7zO

    Article  PubMed  CAS  Google Scholar 

  19. C Gisbert M Prieto M Berenguer M Breto D Carrasco M de Juan et al. (1997) ArticleTitleHyperlipidemia in liver transplant recipients: prevalence and risk factors Liver Transpl Surg 3 416–22 Occurrence Handle9346772 Occurrence Handle10.1002/lt.500030409 Occurrence Handle1:STN:280:DyaK1c%2Fgtleqsw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  20. D Mathe R Adam C Malmendier M Gigou JF Lontie D Dubois et al. (1992) ArticleTitlePrevalence of dyslipidemia in liver transplant recipients Transplantation 54 167–70 Occurrence Handle1631928 Occurrence Handle1:CAS:528:DyaK3sXpvFKksQ%3D%3D

    PubMed  CAS  Google Scholar 

  21. RM Jindal RA Sidner D Hughes MD Pescovitz SB Leapman ML Milgrom et al. (1996) ArticleTitleMetabolic problems in recipients of liver transplants Clin Transplant 10 213–7 Occurrence Handle8664522 Occurrence Handle1:STN:280:DyaK283ntV2rtg%3D%3D

    PubMed  CAS  Google Scholar 

  22. MD Stegall G Everson G Schroter B Bilir F Karrer I Kam (1995) ArticleTitleMetabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity Transplantation 60 1057–60 Occurrence Handle7491685 Occurrence Handle1:STN:280:DyaK28%2Fmslyjug%3D%3D

    PubMed  CAS  Google Scholar 

  23. R Charco C Cantarell V Vargas L Capdevila JL Lazaro E Hidalgo et al. (1999) ArticleTitleSerum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy Liver Transpl Surg 5 204–8 Occurrence Handle10226111 Occurrence Handle10.1002/lt.500050303 Occurrence Handle1:STN:280:DyaK1M3ksVyitQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  24. JM Rabkin V de La Melena SL Orloff CL Corless HR Rosen AJ Olyaei (2001) ArticleTitleLate mortality after orthotopic liver transplantation Am J Surg 181 475–9 Occurrence Handle11448447 Occurrence Handle10.1016/S0002-9610(01)00595-5 Occurrence Handle1:STN:280:DC%2BD3Mzpslahtw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  25. C Fernandez-Miranda A De la Calle C Loinaz E Moreno (1999) ArticleTitleHyperlipidemia in liver transplanted patients Rev Esp Enferm Dig 91 645–9 Occurrence Handle10502713 Occurrence Handle1:STN:280:DyaK1Mvjtl2htA%3D%3D

    PubMed  CAS  Google Scholar 

  26. D Kniepeiss F Iberer S Schaffellner E Jakoby D Duller Tscheliessnigg Kh (2004) ArticleTitleDyslipidemia during sirolimus therapy in patients after liver transplantation Clin Transplant 18 642–6 Occurrence Handle15516237 Occurrence Handle10.1111/j.1399-0012.2004.00253.x Occurrence Handle1:STN:280:DC%2BD2crksV2jsw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  27. A Roy N Kneteman L Lilly P Marotta K Peltekian C Scudamore et al. (2006) ArticleTitleTacrolimus as intervention in the treatment of hyperlipidemia after liver transplant Transplantation 82 494–500 Occurrence Handle16926593 Occurrence Handle10.1097/01.tp.0000231711.82193.41 Occurrence Handle1:CAS:528:DC%2BD28XotlOitbs%3D

    Article  PubMed  CAS  Google Scholar 

  28. B Fellstrom (2000) ArticleTitleImpact and management of hyperlipidemia posttransplantation Transplantation 70 IssueID11 Suppl S51–7

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Organ Transplantation Center, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran

    Seyed Mohsen Dehghani, Seyed Ali Reza Taghavi, Siavash Gholami, Mohammad Hadi Imanieh & Seyed Ali Malek-Hosseini

  2. Pediatric Office, Gastroenterohepatology Research Center, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, 71997-11351, Iran

    Seyed Mohsen Dehghani, Seyed Ali Reza Taghavi, Ahad Eshraghian & Mohammad Hadi Imanieh

  3. Department of Pediatrics, Shiraz University of Medical Sciences, Shiraz, Iran

    Seyed Mohsen Dehghani & Mohammad Reza Bordbar

Authors
  1. Seyed Mohsen Dehghani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Seyed Ali Reza Taghavi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ahad Eshraghian
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Siavash Gholami
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mohammad Hadi Imanieh
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mohammad Reza Bordbar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Seyed Ali Malek-Hosseini
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dehghani, S., Taghavi, S., Eshraghian, A. et al. Hyperlipidemia in Iranian liver transplant recipients: prevalence and risk factors. J Gastroenterol 42, 769–774 (2007). https://doi.org/10.1007/s00535-007-2092-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-007-2092-2

Key words

Search

Navigation